Save information for later
Sign Up

Learn About Budd-Chiari Syndrome

What is the definition of Budd-Chiari Syndrome?
Budd-Chiari syndrome is a rare disorder characterized by obstruction of the veins of the liver that carry the blood flow from the liver. When the blood flow out of the liver is impeded, blood backs up in the liver, causing it to enlarge (hepatomegaly). The spleen may also enlarge (splenomegaly). This backup of blood increases blood pressure in the portal vein, which carries blood to the liver from the intestines (portal hypertension), and result in dilated, twisted veins in the esophagus (esophageal varices). Portal hypertension, leads to fluid accumulating in the abdomen (called ascites). The clot may extend to also block the inferior vena cava (the large vein that carries blood from the lower parts of the body to the heart). Varicose veins in the abdomen near the skin's surface may develop and become visible. In some cases, scarring of the liver (cirrhosis) occurs. Other symptoms may include fatigue, abdominal pain, nausea, jaundice and bleeding in the esophagus. The severity of the disorder varies from case to case, depending on the site and number of affected veins. It most often occurs in patients which have a disorder that makes blood more likely to clot, such as those who are pregnant or who have a tumor, a chronic inflammatory disease, a clotting disorder, an infection, or a myeloproliferative disorder. In about one third of the cases, the cause of Budd-Chiari syndrome is unknown.
What are the alternative names for Budd-Chiari Syndrome?
  • Budd-Chiari syndrome
  • Membranous obstruction of the inferior vena cava
Who are the top Budd-Chiari Syndrome Local Doctors?
Experienced in Budd-Chiari Syndrome
Internal Medicine
Experienced in Budd-Chiari Syndrome
Internal Medicine

Vel Natesan MD PA

951 A Mt Hermon Rd, 
Salisbury, MD 
 (1.3 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Vel Natesan is an Internal Medicine provider in Salisbury, Maryland. Dr. Natesan and is rated as an Experienced provider by MediFind in the treatment of Budd-Chiari Syndrome. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Endoscopy, and Pacemaker Implantation. Dr. Natesan is currently accepting new patients.

Distinguished in Budd-Chiari Syndrome
Gastroenterology | Hepatology
Distinguished in Budd-Chiari Syndrome
Gastroenterology | Hepatology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (83.9 mi)
Languages Spoken:
English, Turkish
Accepting New Patients

Ahmet Gurakar is a Gastroenterologist and a Hepatologist in Baltimore, Maryland. Dr. Gurakar and is rated as a Distinguished provider by MediFind in the treatment of Budd-Chiari Syndrome. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant. Dr. Gurakar is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Budd-Chiari Syndrome
Gastroenterology
Distinguished in Budd-Chiari Syndrome
Gastroenterology
600 N Wolfe St, 1830 Bldg, Rm 420, 
Baltimore, MD 
 (83.9 mi)
Experience:
26+ years
Languages Spoken:
English

Saleh Alqahtani is a Gastroenterologist in Baltimore, Maryland. Dr. Alqahtani has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Budd-Chiari Syndrome. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Obesity, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

What are the latest Budd-Chiari Syndrome Clinical Trials?
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for the Treatment of Portal Hypertension: an Observational Study

Summary: Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial. Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 m...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India

Summary: There is a need to re-evaluate the patients classified as NCPH and determine whether the new histological classification proposed by the VALDIG applies to the Indian scenario. We intend to identify the patient cohorts who have been diagnosed as NCPH, NCPF, EHPVO, hepatic venous outlet tract obstruction (HVOTO), Veno-occlusive disease (VOD) and sinusoidal obstruction syndrome (SOS) based on their l...

Who are the sources who wrote this article ?

Published Date: May 06, 2022
Published By: Genetic and Rare Diseases Informnation Center